Silex Systems Provides Information About Changes In Board

Silex Systems Provides Information About Changes In Board

Silex Systems Limited (ASX: SLX) has recently announced about the below changes in its board:

  1. Retirement of Chair
  2. Retirement of Non-Executive Director
  3. Appointing of new Chair-person
  4. Appointment of Non-Executive Director

Dr. Lisa McIntyre will retire as a Chair-person from the Board of the Company. This will be in effect from the close of business of 31 December 2018. Lisa has been serving as a non-executive Director of the company since July 2012, and as a Chair-person since June 2014. Lisa McIntyre serves as a board member of several other organizations and has decided to resign to devote more time to the other commitments. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Mr. Robert Lee will retire as the Non-Executive Director of the Silex Board, which will be effective from the close of business of 31 December 2018. Robert was appointed as a director in July 2015. The Board in appreciation of Dr. McIntyre and Mr. Lee wanted to thank for their significant contribution and guiding Silex during periods of challenge, upheaval and transition phase of the company when it went through a major restructuring from 2014 and their efforts on the recent restructuring for the exclusive Licensee GE-Hitachi Global Laser Enrichment LLC of the company.

Craig Roy has been appointed as the Non-Executive Director and Chair of the company, which will be in effect from 1 January 2019. Craig was a Deputy CEO of the CSIRO from 2010 to 2018, Australia’s distinguished national science and technology organization. Craig also held various director-level positions within the organization from 2003. Craig has extensive experience in research and commercialization strategy, innovation and entrepreneurship across a vast range of global projects and industry sectors. His experience will be significant and an asset to the board of the company.

Craig also held various vital positions as director and Chair-person in many reputed Australian organizations. He was a member of Data 61, the Australian National Commission of UNESCO, University of Technology, Sydney Vice Chancellor’s Industry Board. He is also the Chair of Australian Research Data Commons (ARDC).

The Board has appointed Melissa Holzberger as a Non-Executive Director of the company, which will be in effect from 1 January 2019. Melissa has experience as a company director and a commercial lawyer. She has significant experience in the energy and resources sector. Moreover, she is a specialist in international nuclear law, regulatory compliance, and trade, and have relevant experience in the global uranium market also, with her experience in BHP Billiton and Rio Tinto. Melissa is currently a member of the Australian Radiation Protection and Nuclear Safety Agency’s (ARPANSA) Radiation Health and Safety Advisory Council and holds a Non-Executive Director position for Tyre Stewardship Australia Limited and Australian Livestock Export Corporation Limited.

Let us quickly review the performance of the Silex’s stock and the returns it has produced over the past few months. Silex’s shares last traded at $0.180. It has yielded a negative YTD return of 65.59% and produced negative return of 20.00% in the past six months. The stock has a 52-week high price of $0.520 and a 52-week low of $0.150.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report